BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 24289591)

  • 1. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effective analysis of recall methods for cervical cancer screening in Selangor--results from a prospective randomized controlled trial.
    Rashid RM; Ramli S; John J; Dahlui M
    Asian Pac J Cancer Prev; 2014; 15(13):5143-7. PubMed ID: 25040965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the phone call the most effective method for recall in cervical cancer screening?--results from a randomised control trial.
    Abdul Rashid RM; Mohamed M; Hamid ZA; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5901-4. PubMed ID: 24289597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting the Australian system: is an organized screening program feasible in Malaysia?--an overview of cervical cancer screening in both countries.
    Rashid RM; Dahlui M; Mohamed M; Gertig D
    Asian Pac J Cancer Prev; 2013; 14(3):2141-6. PubMed ID: 23679334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a worksite cervical screening initiative to increase Pap smear uptake in Malaysia: a cluster randomized controlled trial.
    Abdullah F; O'Rorke M; Murray L; Su TT
    Biomed Res Int; 2013; 2013():572126. PubMed ID: 24073411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the Transtheoretical Model to evaluate the effect of a call-recall program in enhancing Pap smear practice: a cluster randomized trial.
    Abdullah F; Su TT
    Prev Med; 2013; 57 Suppl():S83-6. PubMed ID: 23415623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the prevalence of cervical cancer screening in Malaysia: a nationwide survey.
    Chan YM; Ismail MZH; Khaw WF
    BMC Womens Health; 2023 Jul; 23(1):389. PubMed ID: 37491253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Uptake of Cervical Cancer Screening Among African Women in Klang Valley, Malaysia.
    Nwabichie CC; Manaf RA; Ismail SB
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):825-831. PubMed ID: 29582641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
    Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
    Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
    Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
    BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical screening uptake and its predictors among rural women in Malaysia.
    Gan DE; Dahlui M
    Singapore Med J; 2013 Mar; 54(3):163-8. PubMed ID: 23546031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probability of early repeat Pap smear in an integrated cervical screening programme.
    Rosso A; Foglietta F; Naldoni C; Schincaglia P; Buzzi G; Camprincoli S; Serafini M; Busoli S; Leoni F; Grilli N; Bucchi L
    Eur J Cancer Prev; 2000 Aug; 9(4):269-74. PubMed ID: 10958330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.